According to Gossamer Bio's latest financial reports the company has a price-to-book ratio of 2.43.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 3.28 | -80.7% |
2022-12-31 | 17.0 | 138.43% |
2021-12-31 | 7.12 | 219.61% |
2020-12-31 | 2.23 | -18.49% |
2019-12-31 | 2.73 | |
2018-12-31 | N/A | |
2017-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | 2.43 | -0.24% | ๐บ๐ธ USA |